,,iv #aafth ,,congress #ast ,session ,h4 ,,res4 #fjf ,,in ,,the ,,house ,,of ,,representatives ,september #bg1 #bjai,ms4 ,lee of ,california 7for herself1 ,mr4 ,burgess1 ,mr4 ,danny ,k4 ,davis of ,illinois1 ,mr4 ,serrano1 ,ms4 ,sewell of ,alabama1 ,ms4 ,jackson ,lee1 ,ms4 ,norton1 ,mr4 ,brown of ,maryland1 ,mr4 ,cohen1 ,ms4 ,tlaib1 ,mr4 ,david ,scott of ,georgia1 and ,ms4 ,fudge7 submitted the following resolution2 which was referred to the ,committee on ,energy and ,commerce ,,resolution ,calling for sickle cell trait research1 surveillance1 and public education and awareness1 and for other purposes4 ,whereas sickle cell disease is the most common inherited blood disorder in the ,united ,states1 affecting approximately #ajj1jjj people in the ,united ,states2 ,whereas more than #c1jjj1jjj people in the ,united ,states have the sickle cell trait1 and many are unaware of their status2 ,whereas in #bjaj1 the total number of babies born with sickle cell trait was estimated to have exceeded #fj1jjj1 and the total ,united ,states incidence estimate was #ae4e cases per #a1jjj births2 ,whereas sickle cell disease occurs in about #a out of every #cfe ,black or ,african-,american births and #a out of every #af1cjj ,hispanic-,american births2 ,whereas individuals who have sickle cell trait have a #ej-percent chance of passing on the abnormal sickle cell gene to future offspring and #be-percent chance of having future children with sickle cell disease if both parents have the trait2 ,whereas sickle cell disease can be identified before birth by testing a sample of amniotic fluid or tissue from the placenta2 ,whereas individuals with sickle cell trait have the same life expectancy as the general population1 but are at risk for certain conditions1 including blood in the urine1 kidney cancer1 complications with trauma to the eye1 and tissue death in the spleen at high altitudes1 or may have a false positive ,a#a;,c test2 ,whereas during the #aaeth ,congress1 ,public ,law #aae-cbg reauthorized a sickle cell disease prevention and treatment demonstration program and provided for sickle cell research1 surveillance1 prevention1 and treatment2 ,whereas following the enactment of ,public ,law #aae-cbg1 the ,national ,institutes of ,health launched the ,cure ,sickle ,cell ,initiative aimed at bringing genetic therapies into first-in-human clinical trials within five years and moving newly developed genetic therapies1 including gene-editing approaches1 into clinical research2 ,whereas communication of a screening result consistent with sickle cell trait should always be accompanied by appropriate counseling on the implications1 provided by an individual with adequate training and understanding of the information2 ,whereas the limited research on the communication of sickle cell trait test results to patients demonstrates that there is a high prevalence of misleading information being communicated during counseling sessions for sickle cell trait following newborn screening by clinicians2 and ,whereas no studies have examined whether information on sickle cell trait test results is being accurately transmitted to an individual1 whether by a family member or health care provider1 prior to a person's reproductive years3 ,now1 therefore1 be it ,that the ,house of ,representatives-- 7#a7 recognizes the importance of ensuring that people in the ,united ,states can make informed decisions as a result of awareness of their sickle cell trait status2 7#b7 recognizes the ongoing challenges in addressing health outcomes among people with sickle cell trait and sickle cell disease2 7#c7 recognizes the importance of the development of1 and access to1 new treatments for sickle cell disease2 7#d7 encourages the medical community1 in coordination with ,state and ,federal government1 to work to ensure that all individuals are made aware of their sickle cell trait status by developing a common strategy for dissemination of screening results1 education1 and counseling to parents and families in collaboration with all #ej ,states' newborn screening programs2 7#e7 calls on the ,department of ,health and ,human ,services1 in collaboration with experts1 to develop a surveillance and public awareness campaign regarding the importance of knowing one's sickle cell trait status and to gain knowledge on sickle cell disease for all racial and ethnic groups in the ,united ,states2 7#f7 commits to build on the progress of ,public ,law #aae-cbg which reauthorized a sickle cell disease prevention and treatment demonstration program and provided for sickle cell research1 surveillance1 prevention1 and treatment2 7#g7 calls on the ,department of ,health and ,human ,services to expand access for screening and appropriate counseling for carriers of sickle cell trait2 7#h7 commits to ensuring support for research that expands our understanding of the health outcomes and other implications of sickle cell trait and the health outcomes associated with sickle cell disease2 and 7#i7 commits to ensuring equitable access among economic1 racial1 and ethnic groups to new treatments in order to improve health outcomes for those with sickle cell disease4